[Treatment of ductus-dependent congenital heart diseases with prostaglandin E1].
作者信息
Lillquist K
出版信息
Ugeskr Laeger. 1979 Jul 9;141(28):1915-6.
PMID:473414
Abstract
摘要
相似文献
1
[Treatment of ductus-dependent congenital heart diseases with prostaglandin E1].
Ugeskr Laeger. 1979 Jul 9;141(28):1915-6.
2
[Prostaglandin treatment of ductus-dependent congenital heart defects].
Lakartidningen. 1984 Oct 3;81(40):3619-22.
3
4
[Prolonged prostaglandin E-1 therapy of newborn infants with congenital heart defects].
Orv Hetil. 1980 May 18;121(20):1197-9.
5
Prostaglandin treatment of newborns with ductal-dependent congenital heart disease.
Pediatr Ann. 1981 Apr;10(4):29-38.
6
Clinical use of prostaglandins and prostaglandin synthetase inhibitors in cardiac problems of the newborn.
Adv Prostaglandin Thromboxane Res. 1980;7:913-6.
7
Prostaglandins and the management of congenital heart disease.
Am Fam Physician. 1982 Dec;26(6):127-32.
8
Morphologic features of the ductus arteriosus after prostaglandin E1 administration for ductus-dependent congenital heart defects.
J Am Coll Cardiol. 1983 Feb;1(2 Pt 1):471-5. doi: 10.1016/s0735-1097(83)80075-8.
9
10
Comments on the pharmacologic manipulation of the ductus arteriosus in newborns.
Adv Prostaglandin Thromboxane Res. 1978;4:383-5.
Zotero 插件